Migraine sufferers soon may have to seek relief elsewhere after GlaxoSmithKline (GSK) announced it temporarily halted the production of two popular Excedrin products.

The move to stop production on both drugs stems from inconsistencies with the ingredients, which are acetaminophen, aspirin, and caffeine.

All this hoopla about Excedrin Migraine being the first OTC migraine medication but look at this.I took this from Excedrin's Website. Extra Strength Excedrin -Drug FactsActive ingredients (in each ...

Learn about common-over-the-counter (OTC) treatments for migraine attacks, including acetaminophen and NSAIDs such as aspirin ...

The company has suspended production and distribution of its Excedrin Extra Strength and Excedrin Migraine products, it said.

Drugmaker Novartis is accused of charging more for Excedrin Migraine than Excedrin Extra Strength, though the two medicines have identical ingredients in the same amounts ...

GlaxoSmithKline has temporarily paused production on two Excedrin medicines used to treat migraine because of some “inconsistencies” in the process of how the drug is made, the company says.

Earlier this year, Excedrin temporarily halted production of two of its popular medications, Excedrin Extra Strength and Excedrin Migraine, due to inconsistencies in ingredients.

Excedrin Migraine and Excedrin Extra Strength have the same active ingredients: acetaminophen, aspirin, and caffeine. So, how are they different?

A GSK spokesperson said there were “inconsistencies in how we transfer and weigh ingredients” for Excedrin Extra Strength Caplets and Geltabs and Excedrin Migraine Caplets and Geltabs.

The maker of Excedrin is temporarily discontinuing two of the brand’s most popular headache-relief medicines, potentially affecting millions of Americans who suffer from migraines.

Pharmaceutical company GlaxoSmithKline says it has temporarily discontinued two types of Excedrin items as a precautionary measure.